Pharmaceutical

Delivery and manufacturing hurdles remain in the cell and gene therapy

Panellists discuss opportunities and challenges in cell and gene therapies at the Advanced Therapies conference in London, UK.

Mar 22, 2024 - 00:00
Delivery and manufacturing hurdles remain in the cell and gene therapy
Panellists discuss opportunities and challenges in cell and gene therapies at the Advanced Therapies conference in London, UK.
Read the original article

Tags:

Previous Article

Capstan secures $175m Series B funds for CAR-T therapy

Next Article

Delivery tech remains challenging with gene therapies for brain disorders

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: The inside story of how data integrity issues roiled a biotech seen as ‘Moderna 2.0’

STAT+: The inside story of how data integrity issues ro...

Jun 12, 2023

STAT+: CVS Health sees Medicare Advantage patients seek more care, eating into profits

STAT+: CVS Health sees Medicare Advantage patients seek...

Jan 8, 2024

STAT+: Congress gives doctors Medicare pay bump, sets up December fight in new funding package

STAT+: Congress gives doctors Medicare pay bump, sets u...

Mar 4, 2024